5. Pharma Sharing Landscape FDA letter to major pharma co. Multiple issues with content Shared via Facebook sharing widget FDA “disliked” it due to: Omission of risk Broadening of indication Superiority claims Overstatement of efficacy Failure to submit
6. So What? First DDMAC letter: Addressing social sharing tools Mentioning Facebook Directly addressing metadata Takeaways: FDA expects compliance Even if there are space limitations Metadata can influence social sharing Must be in compliance
7.
8.
9. Because <meta> tags are designed for SEO, there are cases where the tags are too long to be shared on the target site
10. In these cases, the sharing tool will truncate the message
21. share»send»save Features Allows SEO and social tags to co-exist Enables consistent sharing of specified content Sends secure e-mails that include safety Offers interstitial “leaving site” disclaimer Enhanced tracking, analytics, customization
22. Social Sharing Takeaways Start with relevant content Share with care! Be selective Not everything should be shared Use tools that provide control At the end of the day … Seek the best experience for your end-user AND minimize risk!
23. Spare a square – dare to share – but share with care! sharesendsave.com Thank you!
Introduce Speaker, Topic, Intouch Reference that this is most relevant for pharma and other regulated industries, but also relevant to broader healthcare marketer and communicators as well
Title reminded me of one of my favorite Seinfield episodeIf I had more time, I’d play the clip, but basically …Elaine and Jamie Gertz have a dialogue in the women’s room – Elaine needs toilet paper; Jamie doesn’t have a square to spareElaine repeatedly asks “Do you have a square to spare?” Jamie, alas, does not.What I’m here to ask today is: “Can you dare to share? Not toilet paper, but content.”
The details of the letter indicate that the Facebook sharing feature of the social widget on the website generated communications that were in violation because they:• Failed to provide risk information (omission of risk)• Broadened Tasigna® indication beyond what was approved (broadening of indication)• Implied advantages of Tasigna® over other products (unsubstantiated superiority claims)• Implied the drug is more effective than clinical experience or evidence has proven (overstatement of efficacy)The letter also pointed out that, while the website itself was submitted to FDA per regulations, the shared content was not submitted prior to use (failure to submit).
1st DDMAC letter re: social sharing tools 1st letter that mentions Facebook1st letter directly addressing metadataTakeaways: The message here is that FDA expects compliance with existing regseven if there are space limitations.Metadata can influence your social sharing messaging and therefore must comply with FDA regulations.
Standard drug.comReco from emerging media team is to share @ content level, where relevance is highest
Meta tags are usually thought of as invisible to users & just for search engines, but standard sharing widgets make that content visibleTruncation can lead to issues like broadening of indication, overstatement of efficacy, etc.Facebook is just one example but is a common oneMessage is being truncated in a way that could cause fair balance problemsRandom image is scraped from site & distorted by Facebook
Standard drug.comReco from emerging media team is to share @ content level, where relevance is highest
Safe sharing using “social tags”Desired share-able image can be set® Safe shortened URL prevents claim statement in linkReminder messagingSearcn engines would still see original metadata
share tab for social networks & social bookmarksCan disclaim liability for external sites while passing data & directing users to any of the sitesSame safe social content goes to all
share tab for social networks & social bookmarksCan disclaim liability for external sites while passing data & directing users to any of the sitesSame safe social content goes to all
Send tab for email sharingControls the message of what gets sharedEmails can include drug safety info
Save tab allows users to create bookmarks
Standard drug.comReco from emerging media team is to share @ content level, where relevance is highest
Look on your jump drives for more social sharing information and more details about ShareSendSaveVisit ShareSendSave.com
You’ll find much more information, details, and point of view documents on social sharing on the black jump drives in your bags